ORKA
Oruka Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$40.00
+8.01 ▲ +25.04%
🌙 3월 13일 7:52 PM ET (한국 3/14 08:52)
$39.97
-0.03 ▼ -0.08%
| Index | RUT | P/E | - | EPS (ttm) | -2.32 | Insider Own | 15.6% | Shs Outstand | 0.05B | Perf Week | 21.32% |
| Market Cap | 1.98B | Forward P/E | - | EPS next Y | -12.85% | Insider Trans | -0.51% | Shs Float | 0.04B | Perf Month | 24.19% |
| Enterprise Value | 1.65B | PEG | - | EPS next Q | -0.55 | Inst Own | 97.19% | Short Float | 10.93% | Perf Quarter | 27.39% |
| Income | -0.11B | P/S | - | EPS this Y | -30.2% | Inst Trans | 18.62% | Short Ratio | 8.72 | Perf Half Y | 147.68% |
| Sales | 0.00B | P/B | 4.16 | EPS next 5Y | -20.12% | ROA | -23.84% | Short Interest | 4.47M | Perf YTD | 31.97% |
| Book/sh | 9.63 | P/C | 5.88 | EPS past 3/5Y | 34.61% 37.79% | ROE | -24.69% | 52W High | 9.5% ($36.53) | Perf Year | 259.07% |
| Cash/sh | 6.8 | P/FCF | - | Sales past 3/5Y | - | ROIC | -22.28% | 52W Low | 629.26% ($5.49) | Perf 3Y | 188.27% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 63.93% | Gross Margin | - | Volatility(W/M) | 11.41% 7.37% | Perf 5Y | 45.15% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 2.65 | Perf 10Y | -90.54% |
| Dividend Ex-Date | - | Quick Ratio | 22.37 | EPS Q/Q | 15.38% | Profit Margin | - | RSI (14) | 67.12 | Recom | 1.08 |
| Dividend Gr. 3/5Y | - | Current Ratio | 22.37 | Sales Q/Q | - | SMA20 | 18.31% ($33.81) | Beta | -0.28 | Target Price | $60.67 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | 22.03% ($32.78) | Rel Volume | 3.09 | Prev Close | $31.99 |
| Employees | 68 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 29.26% - | SMA200 | 73.35% ($23.07) | Avg Volume(3M) | 0.51M | Price | $40 |
| IPO | 1997/8/8 | Option/Short | Yes/Yes | Trades | 15598 | Volume | 1,585,367 | Change | 25.04% |
뉴스 로딩 중...